A citation-based method for searching scientific literature

Solange Peters, Olivier Michielin, Stefan Zimmermann. J Clin Oncol 2013
Times Cited: 76



Alexander Drilon, Lu Wang, Adnan Hasanovic, Yoshiyuki Suehara, Doron Lipson, Phil Stephens, Jeffrey Ross, Vincent Miller, Michelle Ginsberg, Maureen F Zakowski, Mark G Kris, Marc Ladanyi, Naiyer Rizvi. Cancer Discov 2013
Times Cited: 351




List of shared articles



Times cited

Scientific Advances in Lung Cancer 2015.
Anne S Tsao, Giorgio V Scagliotti, Paul A Bunn, David P Carbone, Graham W Warren, Chunxue Bai, Harry J de Koning, A Uraujh Yousaf-Khan, Annette McWilliams, Ming Sound Tsao,[...]. J Thorac Oncol 2016
170


Gene aberrations for precision medicine against lung adenocarcinoma.
Motonobu Saito, Kouya Shiraishi, Hideo Kunitoh, Seiichi Takenoshita, Jun Yokota, Takashi Kohno. Cancer Sci 2016
118

Biological therapies in nonsmall cell lung cancer.
Jon Zugazagoitia, Sonia Molina-Pinelo, Fernando Lopez-Rios, Luis Paz-Ares. Eur Respir J 2017
29


Biomarkers in lung adenocarcinoma: a decade of progress.
Lynette M Sholl. Arch Pathol Lab Med 2015
40

Emerging targeted therapies in non-small cell lung cancer.
Nabin Khanal, Apar Kishor Ganti. Expert Rev Anticancer Ther 2016
8

Profiling of Oncogenic Driver Events in Lung Adenocarcinoma Revealed MET Mutation as Independent Prognostic Factor.
Sai F Yeung, Joanna H M Tong, Peggy P W Law, Lau Y Chung, Raymond W M Lung, Carol Y K Tong, Chit Chow, Anthony W H Chan, Innes Y P Wan, Tony S K Mok,[...]. J Thorac Oncol 2015
41

The minority report: targeting the rare oncogenes in NSCLC.
Caroline E McCoach, Robert C Doebele. Curr Treat Options Oncol 2014
9

Prognostic and predictive biomarkers in lung cancer. A review.
Erik Thunnissen, Kimberly van der Oord, Michael den Bakker. Virchows Arch 2014
56

Molecular pathology of lung cancer: current status and perspectives.
Felicitas Oberndorfer, Leonhard Müllauer. Curr Opin Oncol 2018
59


[New targets and new drugs in thoracic oncology].
D Rouviere, E Bousquet, E Pons, J-D Milia, N Guibert, J Mazieres. Rev Mal Respir 2015
1

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, Robert C Doebele, Edward Garon, David E Gerber, Sarah B Goldberg, Peter S Hammerman, Rebecca S Heist, Thomas Hensing,[...]. J Thorac Oncol 2015
97

Section IV: non-small cell lung cancer and malignant melanoma.
Kevin E Fisher, Rathi N Pillai, Ragini R Kudchadkar, Michael R Rossi. Curr Probl Cancer 2014
2

Emerging Biomarkers in Personalized Therapy of Lung Cancer.
Philip T Cagle, Kirtee Raparia, Bryce P Portier. Adv Exp Med Biol 2016
12

Targeted therapies and immunotherapy in non-small-cell lung cancer.
D Cortinovis, M Abbate, P Bidoli, S Capici, S Canova. Ecancermedicalscience 2016
21

Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel.
Douglas B Johnson, Kimberly H Dahlman, Jared Knol, Jill Gilbert, Igor Puzanov, Julie Means-Powell, Justin M Balko, Christine M Lovly, Barbara A Murphy, Laura W Goff,[...]. Oncologist 2014
82


Lung cancer as a paradigm for precision oncology in solid tumours.
Simon Schallenberg, Sabine Merkelbach-Bruse, Reinhard Buettner. Virchows Arch 2017
6

Non-Small Cell Lung Cancer, Version 6.2015.
David S Ettinger, Douglas E Wood, Wallace Akerley, Lyudmila A Bazhenova, Hossein Borghaei, David Ross Camidge, Richard T Cheney, Lucian R Chirieac, Thomas A D'Amico, Todd L Demmy,[...]. J Natl Compr Canc Netw 2015
285

Emerging protein kinase inhibitors for non-small cell lung cancer.
Stephen V Liu, Deepa Subramaniam, George C Cyriac, Feras J Abdul-Khalek, Giuseppe Giaccone. Expert Opin Emerg Drugs 2014
19